Jacques Banchereau
Director/Board Member bij Ascend Biopharmaceuticals Ltd.
Profiel
Jacques Banchereau is currently a Non-Executive Director at Ascend Biopharmaceuticals Ltd.
and a Director-Immunological Science Division at Jax Genomic Medicine.
He was previously the SVP, Head-Inflammation & Virology Discovery at Roche Ltd.
from 2010.
Prior to that, he worked as a Provisional Director at Neovacs SA.
Actieve functies van Jacques Banchereau
| Bedrijven | Functie | Begin |
|---|---|---|
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Corporate Officer/Principal | 06-10-2010 |
| Jax Genomic Medicine | Corporate Officer/Principal | - |
Ascend Biopharmaceuticals Ltd.
 Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Eerdere bekende functies van Jacques Banchereau
| Bedrijven | Functie | Einde |
|---|---|---|
| NEOVACS | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEOVACS | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Finance |
Ascend Biopharmaceuticals Ltd.
Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Health Technology |
| Jax Genomic Medicine |
